Nasal Allergen Challenge - Reproducibility of Biomarkers and Effect of Topical Steroid Treatment
Status:
Unknown status
Trial end date:
2019-02-01
Target enrollment:
Participant gender:
Summary
Subjects with allergic asthma developing the required nasal symptoms in response to nasal
allergen titration during a screening period will be randomized 1:1 to one of 2 cohorts. All
subjects will have repeated nasal challenges with allergen. One cohort will have nasal saline
challenge as control. One cohort will have intranasal corticosteroid intervention.